TRANSVAC: new vaccines faster

Welcome to TRANSVAC, a collaborative infrastructure project funded under the European Commission’s (EC) 7th Framework Programme (FP7). The project is the joint effort of leading European groups in the field of vaccine development, and is coordinated by the European Vaccine Initiative (EVI). TRANSVAC was designed in order to enhance European research and training and foster the seamless implementation of a permanent research infrastructure for early vaccine development in Europe.

In order to reach its ambitious goal, TRANSVAC carries out activities at various levels. On this website you can find out about how to benefit from TRANSVAC’s portfolio of activities, learn how to apply for access to the TRANSVAC’s high-quality Infrastructure Free Services and Paid Services, how to participate in the free Workshops on Animal Models or in the free Modular Course on Concepts on Vaccine Development. Finally, TRANSVAC looks to the future and is exploring the implementation of a road map towards a sustainable European vaccine development platform beyond TRANSVAC. This is done by the European Vaccine Development Stakeholder Working Groups.

News

17 June 2016

EVI moves to new address

As of 15 June 2016 EVI is domiciled at:

European Vaccine Initiative
UniversitätsKlinikum Heidelberg
Vossstrasse 2, Geb. 4040
69115 Heidelberg, Germany

14 June 2016

VAC2VAC, a new project funded by the Innovative Medicines Initiative (IMI2)

European public and private organisations are collaborating in VAC2VAC, a new project funded by the Innovative Medicines Initiative (IMI2) to develop and validate quality testing approaches for both human and veterinary vaccines using non-animal methods.

27 January 2016

EVI is currently offering three exciting positions

Three new positions offering exciting challenges to qualified applicants are now available at EVI: 

Senior Project Manager, deadline 15 March 2016
Project Manager, deadline 15 March 2016
Programme Manager Assistant, deadline 15 March 2016